HHHero K. Hussain

Hero K. Hussain

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Hero K. Hussain has a total of 24 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Cirrhosis and Hepatocellular Carcinoma

    by Ravinder S. Legha, Khaled M. Elsayes, Hero K. Hussain

  • MRI Endorectal Coil

    by Saroja Adusumilli, Hero Hussain

  • Open Access

    3D excretory MR urography: Improved image quality with intravenous saline and diuretic administration

    by F. Bilge Ergen, Hero K. Hussain, Ruth C. Carlos, Timothy D. Johnson, Saroja Adusumilli, William J. Weadock, Melvyn Korobkin, Isaac R. Francis

    Purpose: To assess the effect of diuretic administration on the image quality of excretory magnetic resonance urography (MRU) obtained following intravenous hydration, and to determine whether intravenous hydration alone is sufficient to produce diagnostic quality studies of nondilated upper tracts.Materials and Methods: A total of 22 patients with nondilated upper tracts were evaluated with contrast‐enhanced MRU. All patients received 250 mL of saline intravenously immediately prior to the examination. A total of 11 patients received 10–20 mg furosemide in addition to saline. Imaging was performed with a three‐dimensional (3D) and two‐dimensional (2D) breathhold spoiled gradient‐echo sequences. Excretory MRU images were acquired five minutes after the administration of 0.1 mmol/kg gadolinium and were independently reviewed by two radiologists, who were blinded to the MRU technique. Readers evaluated the calyces, renal pelvis, and ureters qualitatively for degree of opacification, distention, and artifacts on a four‐point scale. Statistical analysis was performed using a permutation test.Results: There was no significant disagreement between the two readers (P = 0.14). Furosemide resulted in significant improvement in calyceal and renal pelvis distention (P < 0.005), and significant artifact reduction in all upper tract segments (P < 0.001) compared to the effect of saline alone.Conclusion: Intravenous furosemide significantly improves the image quality of excretory MRU studies obtained following intravenous hydration. Intravenous saline alone is insufficient to produce diagnostic quality studies of the non‐dilated upper tracts. J. Magn. Reson. Imaging 2007.


  • T2-weighted MR Imaging in the Assessment of Cirrhotic Liver

    by Hero K. Hussain, Ibrahim Syed, Hanh V. Nghiem, Timothy D. Johnson, Ruth C. Carlos, William J. Weadock, Isaac R. Francis

    To assess if T2-weighted magnetic resonance (MR) imaging provides added diagnostic value in combination with dynamic gadolinium-enhanced MR imaging in the detection and characterization of nodular lesions in cirrhotic liver. Two readers retrospectively and independently analyzed 54 MR imaging studies in 52 patients with cirrhosis. In session 1, readers reviewed T1-weighted and dynamic gadolinium-enhanced images. In session 2, readers reviewed T1-weighted, dynamic gadolinium-enhanced, and respiratory-triggered T2-weighted fast spin-echo images. Readers identified and characterized all focal lesions by using a scale of 1-4 (1, definitely benign; 4, definitely malignant). Multireader correlated receiver operating characteristic (ROC) analysis was employed to assess radiologist performance in session 2 compared with session 1. The difference in the areas under the ROC curves for the two sessions was tested. In a third session, readers assessed conspicuity of biopsy-proved lesions on T2-weighted MR images by using a scale of 1-3 (1, not seen; 3, well seen) and identified causes of reduced conspicuity. Two additional benign lesions were detected by each reader in session 2. Fifty-five lesions had pathologic verification, including 32 malignant, three high-grade dysplastic, and 20 benign nodules. There was no significant difference in the area under the ROC curves between the two sessions (P =.48). Thirty-two lesions were inconspicuous on T2-weighted MR images because of parenchymal heterogeneity, breathing artifacts (particularly in patients with ascites), and lesion isointensity with liver parenchyma. T2-weighted MR imaging was useful in the evaluation of cysts and lymph nodes. T2-weighted MR imaging does not provide added diagnostic value in the detection and characterization of focal lesions in cirrhotic liver.


  • Open Access

    Magnetic resonance imaging of cholangiocarcinoma

    by Katrina A Vanderveen, Hero K Hussain

    Magnetic resonance imaging of cholangiocarcinoma - Cancer Imaging Magnetic resonance imaging of cholangiocarcinoma - Preoperative imaging with MRI/MRA/MRCP is an accurate non-invasive method for staging cholangiocarcinoma,and determining resectability. It provides information regarding tumor size, extent of bile duct involvement, vascularpatency, extrahepatic extension, nodal or distant metastases, and the presence of lobar atrophy. MRCP is better fordemonstrating bile ducts distal to the stricture, although with ERCP, therapeutic intervention such as stent placementand biopsy can be performed.


    • 1 May 2003
      • Vol. 9  (5) , 1666-72

    Phase II trial of tetrathiomolybdate in patients with advanced kidney cancer.

    by Bruce G Redman, Peg Esper, Quintin Pan, Rodney L Dunn, Hero K Hussain, Thomas Chenevert, George J Brewer, Sofia D Merajver

    Tetrathiomolybdate (TM), a copper-lowering agent, has been shown in preclinical murine tumor models to be antiangiogenic. We evaluated the antitumor activity of TM in patients with advanced kidney cancer in a Phase II trial. Fifteen patients with advanced kidney cancer were eligible to participate in this trial. TM was initiated p.o. at 40 mg three times a day with meals and 60 mg at bedtime to deplete copper. A target serum ceruloplasmin (CP) level of 5-15 mg/dl was defined as copper depletion. Doses of TM were reduced for grade 3-4 toxicity and to maintain a CP level in the target range. Once copper depletion was attained, patients underwent baseline tumor measurements and then again every 12 weeks for response assessment. Patients not exhibiting progressive disease at 12 weeks after copper depletion continued on treatment. Serum levels of Interleukin (IL)-6, IL-8, vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF) were assayed pretreatment and at various time points on treatment. Dynamic contrast enhanced-magnetic resonance imaging (DCE-MRI) was performed on selected patients in an attempt to assess changes in tumor vascularity. All of the patients rapidly became copper depleted. Thirteen patients were evaluable for response. No patient had a complete response or PR. Four patients (31%) had stable disease for at least 6 months during copper depletion (median, 34.5 weeks). TM was well tolerated, with dose reductions most commonly occurring for grade 3-4 granulocytopenia of short duration not associated with febrile episodes. Serum levels of IL-6, IL-8, VEGF, and bFGF did not correlate with clinical activity. Serial DCE-MRI was performed only in four patients, and a decrease in vascularity seemed to correlate with necrosis of a tumor mass associated with tumor growth. TM is well tolerated and consistently depletes copper as measured by the serum CP level. Clinical activity was limited to stable disease for a median of 34.5 weeks in this Phase II trial in patients with advanced kidney cancer. Serum levels of proangiogenic factors IL-6, IL-8, VEGF, and bFGF may correlate with copper depletion but not with disease stability in this small cohort. TM may have a role in the treatment of kidney cancer in combination with other antiangiogenic therapies.


  • Hepatic Arterial Phase MR Imaging with Automated Bolus-Detection Three-dimensional Fast Gradient-Recalled-Echo Sequence: Comparison with Test-Bolus Method

    by Hero K. Hussain, Frank J. Londy, Isaac R. Francis, Hanh V. Nghiem, William J. Weadock, Achamyeleh Gebremariam, Thomas L. Chenevert

    Sixty-two patients underwent magnetic resonance (MR) imaging of the liver with the automated contrast material bolus-detection technique. Arterial phase MR images were assessed quantitatively and qualitatively. In 23 patients, a test bolus of contrast material was injected intravenously before dynamic MR imaging. There was good correlation and agreement between delay times estimated with both timing methods. Eighty-three percent of arterial phase images obtained with automated contrast material bolus detection were optimal. There was good correlation and agreement between delay times estimated with both timing methods. Optimal hepatic arterial phase MR images can be obtained routinely with automated detection of a contrast material bolus.


  • Gadolinium-Ethoxybenzyl-Diethylenetriamine Pentaacetic Acid as an Intrabiliary Contrast Agent: Preliminary Assessment

    by Ruth C. Carlos, Hero K. Hussain, Julie H. Song, Isaac R. Francis

    OBJECTIVE. We assessed the added efficacy of gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid (gadolinium-EOB) in depicting biliary structures compared with T2-weighted MR cholangiopancreatography (T2-MRCP) and measured reviewer preference and willingness-to-pay for the added value of biliary contrast. SUBJECTS AND METHODS. Ten patients prospectively underwent T2-MRCP and gadolinium-EOB—enhanced MR cholangiography (EOB-MRC). Three radiologists reviewed the unpaired, then the paired, examinations, rating biliary visualization using a 5-point scale. The common bile, right and left hepatic ducts, and second-order branches were evaluated. Improved biliary visualization using paired over unpaired tests indicated the added value of contrast media. Kappa values measured interobserver reliability. A regression model controlling for fixed effects due to reviewer and subject correlation quantified improvement in ratings attributable to paired review. RESULTS. Average visualization ratings for unpaired review of EOB-MRC were the following: common bile duct, 3.3; right hepatic duct, 2.7; left hepatic duct, 2.5; second-order branches, 1.4. Average visualization ratings for unpaired review of T2-MCRP were the following: common bile duct, 3.4; right hepatic duct, 1.8; left hepatic duct, 2.2; second-order branches, 0.9. Ratings improved using paired tests over EOB-MRC and T2-MRCP for all structures (p < 0.001) except for T2-MRCP common bile duct ratings (p > 0.05). Agreement was moderate to good except for EOB-MRC common bile duct ratings. Paired review improved ratings (χ2 < 0.0001) over T2-MRCP alone by 1.05 and over EOB-MRC alone by 0.68. Despite significant improvement, reviewers preferred unpaired T2-MRCP (53%) over unpaired EOB-MRC (17%) or paired tests (30%). Reviewers were willing to pay $25 (median) for gadolinium-EOB. CONCLUSION. Combining T2-MRCP and EOB-MRC significantly improved biliary visualization over each test alone. However, improvement was small, and the perceived added value of gadolinium-EOB was modest.


  • Imaging of hepatic transplantation

    by Hero K Hussain, Hanh Vu Nghiem